AI Assistant
Blog
Pricing
Log In
Sign Up
EPSTI1 as an immune biomarker predicts the prognosis of patients with stage III colon cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
